Astera Labs, Inc. — Director's Dealing 2025

Jun 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2025-05-30

Reporting Person: Tate Michael Truett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-30	Common Stock	S	19998	$88.1442	Disposed	1098998	Indirect
2025-05-30	Common Stock	S	92200	$89.0485	Disposed	1006798	Indirect
2025-05-30	Common Stock	S	156288	$90.0648	Disposed	850510	Indirect
2025-05-30	Common Stock	S	204954	$90.7509	Disposed	645556	Indirect
2025-05-30	Common Stock	S	15492	$92.0366	Disposed	630064	Indirect
2025-05-30	Common Stock	S	3968	$92.959	Disposed	626096	Indirect
2025-05-30	Common Stock	S	7100	$94.328	Disposed	618996	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	235135	Direct

Footnotes

F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.5200 to $88.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.5200 to $89.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.5200 to $90.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.5200 to $91.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.5200 to $92.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.5400 to $93.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.0400 to $94.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.